Cancer Genetics, Inc. Awarded $1.8 Million In Non-Dilutive Financing From New Jersey's Technology Business Tax Certificate Transfer Program
1/21/2014 8:55:27 AM
RUTHERFORD, N.J., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, announced that it has been awarded approximately $1.8 million, net of transaction costs, in non-dilutive financing via the State of New Jersey's Technology Business Tax certificate Transfer program.
Help employers find you! Check out all the jobs and post your resume.
comments powered by